+ cells/Cryopreservation/Radiosensitive/Stromal cells. In our previous study (Life Sciences 84: 598, 2009), we demonstrated that placental/umbilical cord blood-derived mesenchymal stem cell-like stromal cells have the effect to support the regeneration of freshly prepared X-irradiated hematopoietic stem/progenitor cells (HSPCs). Generally, HSPCs are supplied from companies, institutions, and cell banks that cryopreserve them for clinical and experimental use. In this study, the influence of cryopreservation on the responses of HSPCs to irradiation and co-culture with stromal cells is assessed. After cryopreservation with the optimal procedure, 2 Gy-irradiated HSPCs were cultured with or without stromal cells supplemented with combination of interleukin-3, stem cell factor, and thrombopoietin. The population of relatively immature CD34 + /CD38 -cells in cryopreserved cells was significantly higher than in fresh cells prior to cryopreservation; furthermore, the hematopoietic progenitor populations of CD34 + /CD45RA + cells and CD34 + /CD117 + cells in cryopreserved cells were significantly lower than that in fresh cells. However, the rate of expansion in the cryopreserved HSPCs was lower than in the fresh HSPCs. In the culture of cryopreserved cells irradiated with 2 Gy, the growth rates of CD34 + cells, CD34 + /CD38 -cells, and hematopoietic progenitors were greater than growth rates of their counterparts in the culture of fresh cells. Surprisingly, the effect to support the hematopoiesis in co-culture with stromal cells was never observed in the X-irradiated HSPCs after cryopreservation. The present results demonstrated that cryopreserving process increased the rate of immature and radio-resistant HSPCs but decreased the effects to support the hematopoiesis by stromal cells, thus suggesting that cryopreservation changes the character of HSPCs.
INTRODUCTION
The hematopoietic stem cell (HSC) has the potential to produce all the functional hematopoietic cells. 1) By tapping this potential, HSC transplantation has been utilized worldwide. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] In particular, allogeneic HSC transplantation using the bone marrow or placental/umbilical cord blood (CB) is achieving effective results in the therapy of various hematopoietic diseases such as leukemia, lymphoma, myelodysplasia, aplastic anemia, hemoglobinopathies, metabolic storage diseases, and immunodeficiencies. 13, 14) In addition, this medical treatment has also been used in victims of accidental irradiation for the reconstitution of their hematopoietic function. 15) In the case of a lethal neutron-irradiation nuclear accident that occurred in Japan in 1999, one patient received a bone marrow transplantation while another received a CB transplantation. [16] [17] [18] We have reported the potential efficacy of human mesenchymal stem cell-like stromal cells prepared from CB for hematopoietic regeneration from irradiated hematopoietic stem/progenitor cells (HSPCs). 19) Although the fresh HSPCs were often used in our study as well as other studies because of the close connection to a hospital, the general supply of HSPCs depends on various companies, institutions, and cell banks that cryopreserve them for clinical and experimental use. On the other hand, the risk estimation for radio-sensitive hematopoietic systems and the emergent treatment of radiogenic sickness during space flight have been necessary for the development of space programs. 20) The use of cryopreserved human HSPCs is one of the methods utilized in these therapy. However, the proliferating capacities of cryopreserved HSPCs are generally quite lower in comparison to those of freshly prepared HSPCs. 21, 22) Furthermore, a precise investigation regarding the ex vivo co-culture system for expansion of cryopreserved HSPCs is much needed.
In order to examine these issues, we cryopreserved and thawed human CD34 + cells prepared from CB, and then evaluated the proliferating capacities of these cells in our co-culture system of mesenchymal stem cells. In addition, responses of cryopreserved cells to high dose radiation were compared with those of fresh cells.
MATERIALS AND METHODS

Growth factors and reagents
Recombinant human interleukin-3 (IL-3), stem cell factor (SCF) and thrombopoietin (TPO) were purchased from Bio Source (Tokyo, Japan). Recombinant human erythropoietin (EPO) and granulocyte colony-stimulating factor (G-CSF) were purchased from Sankyo Co. Ltd. (Tokyo, Japan). Recombinant human granulocyte-macrophage colonystimulating factor (GM-CSF) was purchased from Pepro Tech Inc. (NJ, USA). Recombinant human fibroblast growth factor-2 (FGF-2) was provided by Kaken Pharmaceutical Co. Ltd. (Tokyo, Japan). These factors were added at the following concentrations: IL-3 and SCF, 100 ng/ml; TPO, 50 ng/ml; EPO, 4 U/ml; G-CSF, GM-CSF and FGF-2, 10 ng/ml medium. The fluorescence-labeled monoclonal antibodies (mAbs), fluorescein isothiocyanate (FITC)-conjugated anti-human CD13 (CD13), FITC-conjugated anti-human CD34 (CD34), FITC-conjugated anti-human CD41 (gpIIbIIIa, CD41), FITC-conjugated anti-human CD235a (CD235a), phycoerythrin (PE)-conjugated anti-human CD14 (CD14), PE-conjugated anti-human CD38 (CD38), PE-CD41, PEconjugated anti-human CD105 (CD105), PE-cyanin-5-forochrome tandem (PC5)-conjugated anti-human CD15, PC5-conjugated anti-human CD117 (CD117), and PC5-conjugated anti-human CD123 (CD123) were purchased from Beckman Coulter Immunotech (Marseille, France). PEconjugated anti-human CD45RA (CD45RA), PE-conjugated anti-human CD73 (CD73), and PE-conjugated anti-human CD110 (CD110) were purchased from Becton Dickinson Biosciences (San Jose, CA). Mouse IgG1-FITC, mouse IgG1-PE, mouse IgG1-PC5, and mouse IgG2a-FITC (Beckman Coulter Immunotech) were used for isotype controls.
Collection and purification of CBCD34 + cells
This study was approved by The Committee of Medical Ethics of Hirosaki University Graduate School of Medicine (Hirosaki, Japan). After informed consent was obtained from all the mothers, CB for use in this study was collected after full-term deliveries using a sterile collection bag containing the anticoagulant citrate-phosphate dextrose, according to the guidelines of the Tokyo Cord Blood Bank. These samples were separately isolated and used for each experiment. Within 24 hours after the collection of the CB, lightdensity mononuclear CB cells were separated by centrifugation on a Limphosepar I (1.077 g/ml, Immuno-Biological Laboratories, Takasaki, Japan) for 30 minutes at 300 g and washed three times with phosphate-buffered saline (PBS, St. Louis Sigma, USA) containing 5 mM ethylenediaminetetraacetic acid (EDTA 
Cryopreservation and thawing of purified CD34
+ cells
The expression of CD34, CD38, CD45RA, CD110 (cmpl), CD117 (c-kit), and CD123 (IL-3 receptor) in the purified CD34 + cells was measured by flow cytometry. The purified CD34
+ cells were suspended in the freezing medium, containing 60% Isocave's modified Dulbocco's medium (IMDM, Gibco BRL) plus 30% FBS plus 10% dimethyl sulfoxide (Sigma), and then were subsequently cryopreserved at lower than -80°C using BICELL (Nihon Freezer, Tokyo, Japan) as the cryoprotectant. [23] [24] [25] The purified CD34 + cells were thawed and cultured with or without stromal cells after cryopreservation (1 week-10 months). For rapid thawing after cryopreservation, frozen cryogenic vials with Pink Cap (Becton Dickinson and Company, NJ, USA) were taken from the freezer and immediately placed in a 37°C water bath until ice crystals disappeared with shaking. 25, 26) Thawed CD34 + cells were measured by flow cytometry for the antigen expression as mentioned above.
Culture of placental/umbilical CB-derived mesenchymal stem cell-like stromal cells
Mesenchymal stem cell-like stromal cells were previously established by culturing the mononuclear cells excluded from the positive selection of CD34 + cells in Dulbecco's Modified Eagle's Medium (DMEM, Sigma) supplemented with 10% fetal bovine serum (FBS), penicillin (100 U/ml), streptomycin (100 μg/ml) and FGF-2 at 37°C in a humidified atmosphere with 5% CO2 in air. The culture medium was exchanged twice per week. The adherent and expanded cells were considered to be the mesenchymal stem cell-like stromal cells, which were used to perform the co-culture with allogeneic HSPCs. The confirmation that the harvested cells were mesenchymal stem cell-like stromal cells was determined by their expression of antigens characteristic for mesenchymal stem cells, such as CD73, CD90, CD105 and HLA-ABC, using flow cytometry. 19) 
In vitro irradiation of cryopreserved CD34 + cells
The CD34 + cells were irradiated with a dose of 2 Gy at a dose rate of 0.8-0.9 Gy/min of X-rays (200 kVp, 15 mA) with 0.3 mm copper and 0.5 mm aluminum filters at a distance of 45 cm from the focus.
Co-culture of cryopreserved CD34 + cells with stromal cells
Mesenchymal stem cell-like stromal cells were initially cultured in DMEM containing 10% FBS and FGF-2 in a 24-well plate (Becton Dickinson and Company) at a concentration of 3 × 10 4 cells/0.5 ml/well. The next day, the stromal cells were irradiated with a dose of 20 Gy at a dose rate of 3.9-4.2 Gy/min of X-rays (200 kVp, 15 mA) with a 2.0 mm aluminum filter at a distance of 35 cm from the focus to suppress growth. On day 3 after irradiation, the non-irradiated or CD34 + cells irradiated with 2 Gy (2.5 × 10 2 cells/0.5 ml/ well for non-irradiated and 2.5 × 10 3 cells/0.5 ml/well for irradiated) were suspended in serum-free IMDM supplemented with BIT9500 (a serum substitute for serum-free culture, StemCell technologies) and low-density lipoproteins (CALBIOCHEM, Darmstadt, Germany), and then cultured with or without stromal cells at 37°C in a humidified atmosphere with 5% CO2 in air. All the cultures were incubated in the presence of SCF + TPO + IL-3. On day 14, the suspended cells were harvested and the number of viable cells was determined by Trypan blue exclusion.
Flow cytometric analysis
The expression of specific cell-surface antigens was analyzed by direct immuno-fluorescence flow cytometry using single to triple staining combinations of mAbs, including FITC-CD13, FITC-CD34, FITC-CD235a, PE-CD14, PE-CD38, PE-CD41 and PC5-CD15. Briefly, the cells were incubated with the saturated concentrations of the relevant mAbs for 30 minutes at room temperature. After labeling, the cells were washed with PBS and analyzed by flow cytometry. For each experiment, an isotype-matched irrelevant mAb was used as a negative control.
Methylcellulose cultures
The colony-forming cells, including granulocytemacrophage colony-forming unit (CFU-GM), erythroid burst-forming unit (BFU-E) and granulocyte-erythroidmacrophage-megakaryocyte colony-forming unit (CFUMix), were assayed by methylcellulose culturing using MethoCult ® (StemCell technologies). The expanded cells were plated onto each well of a 24-well plate (0.3 ml/well) in the culture medium containing EPO, SCF, IL-3, G-CSF and GM-CSF as colony-stimulating factors. Each plate was incubated at 37°C in a humidified atmosphere with 5% CO2 in air for 14 days. The colonies containing more than 50 cells were counted under an inverted microscope (Olympus, Tokyo, Japan).
Plasma clot culture
The megakaryocyte colony-forming unit (CFU-Meg) was assayed by the plasma clot technique using platelet-poor human plasma. Ten percent human platelet-poor AB plasma, SCF, TPO, penicillin (100 U/ml), streptomycin (100 μg/ml), sodium pyruvate (1 mM), MEM vitamin (1%), MEM nonessential amino acids (1%; GIBCO ® Invitrogen), thioglycerol (1 × 10 -5 M; Sigma), L-asparagine (2 μg/ml), CaCl2 (74 μg/ml; Wako Pure Chemicals, Tokyo, Japan) and 0.2% bovine serum albumin (BSA, Boehringer Mannheim GmbH) were added to the culture medium based on IMDM. Harvested cells were added to the culture medium at a concentration of 2.5 × 10 3 cells/ml. This baseline culture was plated onto a 24-well plate at 0.3 ml/well and was subsequently incubated at 37°C for 14 days in a humidified atmosphere with 5% CO 2 in air.
Identification of megakaryocyte colonies by immunofluorescence
The plasma clot cell cultures were fixed by 15 and 10 minutes incubation in acetone: methanol (2:1). The plates were dried in an air flow overnight and stored at -20°C. Prior to staining, the plates were placed at room temperature, and PBS containing 0.5% BSA (PBS-B) was added to soften the clot. The plates were incubated at room temperature with FITC-CD41 mAb diluted 1:100 in PBS-B for 1 hour followed by a single wash with PBS-B. The nuclei were then counterstained with propidium iodide (0.3 ng/ml, Sigma). After a final wash, the colonies containing more than 3 cells were then counted under an inverted microscope.
Statistical analysis
The data are expressed as the mean ± SD. The comparisons of two different cultures were performed with Student's t-test, Welch's t-test or Mann-Whitney's U-test. The comparisons before and after cryopreservation were performed by a paired t-test or Friedman test. The p-value less than 0.05 was considered to be statistically significant. The statistical analysis was performed using the Excel 2007 software program (Microsoft, USA) with the add-in software program Statcel 2.
27)
RESULTS
The expression of cell-surface antigens on CD34 + cells before and after cryopreservation
The expression of cell-surface antigens on fresh and cryopreserved CD34 + cells was analyzed by flow cytometry (Fig.  1) . After cryopreservation, the population of CD34 + cells, 28, 29) showed a significant increase in comparison to that of fresh cells before cryopreservation (approximately 3.4 ± 1.1% for fresh cells and 5.9 ± 1.3% for cryopreserved cells), although no significant difference was observed in the expression of CD34. On the other hand, the subpopulation of CD34 + /CD45RA + cells, which are progenitors committed to granulocyte and macrophage lineages, 30) and the subpopulation of CD34 + /CD117 + cells, which are relatively immature HSPCs, showed a significant decrease after cryopreservation (approximately 16.0 ± 5.2% and 14.4 ± 9.2% for fresh cells and 9.3 ± 3.3% and 6.9 ± 5.1% for cryopreserved cells, respectively Fig. 2  and 3) . However, no significant difference between the numbers of CD34 + /CD38
-cells in the cultures with or without stromal cells was observed (Fig. 4) .
However, the numbers of total harvested cells, CD34 + cells, and CD34 + /CD38 -cells decreased in X-irradiated cells in comparison to the non-irradiated control. No beneficial effect of stromal cells was observed in X-irradiated cells (Fig. 2, 3 and 4) .
In order to determine the proportions of hematopoietic lineage cells contained in the expanded cells, the expression of immature markers (CD34 and CD38), myeloid lineage markers (CD13, CD14 and CD15), megakaryocytic marker (CD41), and erythrocytic marker (CD235a) was analyzed using flow cytometry ( Table 1) . No significant difference in the proportion of each hemopoietic cell lineage was observed between the non-irradiated and X-irradiated cells. On the other hand, the expression of CD41 was significantly decreased by co-culture with stromal cells in comparison to stroma-free culture in both non-irradiated and X-irradiated conditions. Moreover, the culture with stromal cells increased the expression of CD15 of X-irradiated cells in comparison to the stroma-free culture. 
Ex vivo expansion of hematopoietic progenitor cells in non-irradiated or X-irradiated CD34 + cells after cryopreservation
After ex vivo expansion, the number of lineage-committed hematopoietic progenitor cells including CFU-GM, which are progenitors for granulocyte-macrophages, BFU-E, which differentiate into erythroblasts and erythrocytes, and CFUMix, containing pluripotent hematopoietic progenitors differentiating into erythroid, granulocyte, macrophage and megakaryocytic cells, were assayed using methylcellulose cultures. The total number of hematopoietic progenitor cells, which are colony-forming cells (CFC), was obtained from the sum of each value of CFU-GM, BFU-E, and CFU-Mix (Fig. 5) . In the culture of non-irradiated cells, there was a significant difference between the CFC numbers in the culture with and without stromal cells (5.8 × 10 4 cells and 2.1 × 10 4 cells, respectively); however, the co-culture with stromal cells did not effect the number of CFU-GM, BFU-E and CFU-Mix ( Fig. 5 and 6 ). The co-culture with stromal cells increased the mean values of the number of CFC, CFU-GM, BFU-E and CFU-Mix in comparison to cultures without stromal cells after X-irradiation, although no significant difference was observed. The number of CFU-Meg, which is a progenitor for megakaryocytes and platelets, was assayed using a plasma clot culture. This number tended to decrease after the co-culture with stromal cells in comparison to the cultures without stromal cells in both the non-irradiated and X-irradiated cells (Fig. 7) .
DISCUSSION
Previous reports demonstrated that immature HSPCs, such as CD34 + /CD38
-cells, have a capacity to survive environmental stress such as extremely low temperature. 15, 31, 32) Meanwhile, Broxmeyer et al. have reported that CB can be stored frozen for at least 15 years with highly viable and functional hematopoietic stem/progenitor cells for successful CB transplantation.
33) The present study also demonstrated an increase in the population of CD34 + /CD38 -cells after cryopreservation, although no changes were seen in expression rate of CD34. However, the growth rate of CD34 + /CD38
-cells in the culture of non-irradiated cryopreserved cells was lower than that in the culture of the fresh cells shown in our previous study, although the growth rates of total cells and CD34 + cells were equivalent to that in the fresh cells (approximately 1600-and 110-fold increase for fresh cells and 1300-and 110-fold increase for cryopreserved cells, respectively). 19) Consistent with these results, the number of each progenitor cell, CFU-GM, BFU-E and CFU-Mix, after the cryopreservation was smaller than that obtained in the fresh cells, but the number of CFU-Meg was not decreased (Figs. 6 and 7) . These results were consistent with the previous reports that the proliferating capacities of cryopreserved HSPCs are generally quite lower in comparison to the freshly prepared HSPCs. 21, 22) However, the final constitution of hematopoietic cells from cryopreserved HSPCs may be normal because of the existence of cryoresistant immature cells after thawing. A slow proliferation rate in cryopreserved HSPCs may result from the loss of cryo-sensitive hematopoietic progenitor cells such as CD34 + / CD45RA + and CD34 + /CD117 + cells. On the other hand, the capacity to amplify CD34 + cells and CD34 + /CD38 -cells from cryopreserved cells in the co-culture with stromal cells was lower than that of the fresh cells as shown in our previous study (approximately 6.4-and 6.8-fold increase for fresh cells and 2.6-and 2.8-fold increase for cryopreserved cells compared to that of cultures without stromal cells, respectively), although the capacity to amplify total cells and CFC from cryopreserved cells in the co-culture with stromal cells was equivalent with that of the fresh cells. These results suggest that the interaction of cryo-resistant cells and stromal cells for self-renewal is lower or that the stress of freezing and thawing may induce damage to cell-to-cell interaction process, including Notch, Frizzled, or Wnt receptors. Notch and Wnt signaling have been known to maintain, proliferate and control differentiation in the HSPCs. 35) In the culture of X-irradiated cells, the growth rates of (Figs. 2 -7) .
In particular, the capacities of stromal cells to support expansion of the CD34 + cells and CD34 + /CD38 -cells in Xirradiated cryopreserved cells were much lower than that obtained by the fresh cells (approximately 6.9-and 6.5-fold increase for fresh cells and 1.5-and 1.6-fold increase for cryopreserved cells as compared with cultures without stromal cells, respectively). These results suggest that the process of freezing and thawing largely interferes with HSPCs receiving the beneficial effect of stromal cells and that the interaction between HSPCs and stromal cells is important to protect the cells from radiation damage.
In order to evaluate the effects of cryopreservation on ex vivo hematopoiesis, the specific cell-surface antigens were analyzed ( Table 1) . Zweegman et al. suggested that stromal sulfated glycoconjugates contained in human bone marrow stroma inhibited a megakaryocytic differentiation step. 36) In the present study, a decrease in CD41 expression in the coculture with stromal cells was observed similar to our previous data on using fresh cells. However, in contrast to fresh cells, co-cultures of cryopreserved cells with stromal cells increased the mean rate of CD15-positive cells and irradiated cells significantly showed increased expression of CD15 in comparison to control cells without stromal cells (Table 1 and Ref. 19 ). These results show that the responses of HSPCs to stromal cells may change after cryopresevation, thereby promoting the differentiation into the myeloid cell lineage.
In conclusion, the present data demonstrate that the stress of cryopreservation influences the proliferative capacity of HSPCs, suggesting that consideration of these influences is necessary in experiments using cryopreserved HSPCs. In particular, the present results indicate that cryo-resistant cells might possibly include radio-resistant cells. However, the placental/umbilical CB-derived mesenchymal stem celllike stromal cells did not affect the capacities of proliferation and sustaining of immature cells in the culture of irradiated cells after the cryopreservation/thawing process. The treatment of emergent radiogenic sickness has been developed for long stays at the International Space Station and/or a trip to Mars in the future. 37) Langell et al. noted that galactic cosmic radiation and solar energetic particles are known to represent two types of ionizing deep-space radiation. Especially, the largest of solar particle events produce solar particles with a lethal dose.
38) The findings of this report support treatment with high-dose radioprotectant amifostine 30 min prior to undergoing radiation exposure as a pharmacological countermeasure. On the other hand, hematopoietic stem cells must be transplanted to individuals exposed with such a lethal dose immediately after irradiation. At this time, cryopreserved HSPCs, such as a backup of HSPCs, are now scheduled to be taken up into space and they will receive combined damage due to both cryopreservation and irradiation. In space, the cryopreserved HSPCs will receive not only low-linear energy transfer (LET) radiation, such as Xray and γ-ray, but also high-LET radiation, such as proton and α-particle. 39) Therefore, further investigation of the effect of high-LET radiation on the cryopreserved HSPCs will be needed for in the future.
